| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 170.926.406 $ | +4.812.329 $ | +63,2 % | 234.571.025 $ | +74.036.940 $ | +87,3 % | 73.331.558 $ | +36.368.850 $ | +106,9 % | |
| ARCH Venture Management, LLC | 65.138.070 $ | +49.025.459 $ | +304,3 % | ||||||
| GSK plc | 30.343.940 $ | -16.215.704 $ | -34,8 % | 46.559.644 $ | |||||
| MWG Caph Ltd | 31.029.810 $ | ||||||||
| VANGUARD GROUP INC | 25.437.516 $ | +12.786.492 $ | +101,1 % | 12.651.024 $ | +8.738.210 $ | +223,3 % | |||
| Foresite Capital Management IV, LLC | 16.056.004 $ | -8.580.277 $ | -34,8 % | 24.636.281 $ | +11.637.801 $ | +89,5 % | 12.998.480 $ | +5.922.953 $ | +83,7 % |
| Orland Properties Ltd | 15.139.242 $ | -8.090.362 $ | -34,8 % | 23.229.604 $ | +10.973.308 $ | +89,5 % | 12.256.296 $ | +5.584.766 $ | +83,7 % |
| Decheng Capital LLC | 13.882.523 $ | -7.418.776 $ | -34,8 % | 21.301.299 $ | +11.630.931 $ | +120,3 % | 9.670.368 $ | +4.406.449 $ | +83,7 % |
| Almitas Capital LLC | 11.590.808 $ | -6.194.091 $ | -34,8 % | 17.784.899 $ | +8.401.313 $ | +89,5 % | 9.383.586 $ | +4.256.413 $ | +83,0 % |
| MWG Management Ltd. | 16.371.804 $ | +7.460.059 $ | +83,7 % | ||||||
| Foresite Capital Management V, LLC | 9.570.185 $ | -5.114.276 $ | -34,8 % | 14.684.461 $ | +6.936.714 $ | +89,5 % | |||
| CITADEL ADVISORS LLC | 10.486.777 $ | +4.701.423 $ | +81,3 % | ||||||
| venBio Partners LLC | 10.394.314 $ | +2.705.015 $ | +35,2 % | ||||||
| MILLENNIUM MANAGEMENT LLC | 9.205.634 $ | +7.400.356 $ | +409,9 % | ||||||
| Alphabet Inc. | 9.026.420 $ | +4.263.943 $ | +89,5 % | ||||||
| 170.926.406 $ | +4.812.329 $ | +63,2 % | 234.571.025 $ | +74.036.940 $ | +87,3 % | 73.331.558 $ | +36.368.850 $ | +106,9 % | |